| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.7M | +31.9% |
| Cost of Revenue | $7.0M | +34.4% |
| Gross Profit | $3.7M | +27.2% |
| R&D Expense | $132K | +14.8% |
| SG&A Expense | $3.0M | +13.0% |
| Operating Income | -$2.8M | +1.5% |
| Net Income | -$2.8M | -0.0% |
| EPS (Basic) | -$0.19 | +9.5% |
| EPS (Diluted) | -$0.19 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $829K | +1.0% |
| Inventory | $1.5M | +23.6% |
| Current Assets | $2.7M | -34.4% |
| Total Assets | $3.3M | -31.0% |
| Current Liabilities | $2.6M | +13.4% |
| Long-term Debt | $223K | — |
| Total Liabilities | $2.7M | +18.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.2M | +24.6% |
| Capital Expenditures | $53K | — |
| Investing Cash Flow | -$53K | — |
| Financing Cash Flow | $626K | -65.8% |
| Free Cash Flow | -$2.3M | — |
| +9.5% |
| Stockholders' Equity |
| $578K |
| -76.9% |